This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe


  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Pierre Bruhns, PhD
Director, Unit of Antibodies in Therapy & Pathology at Institut Pasteur


Pierre Bruhns performed his PhD in Immunology on antibody receptors (FcR) at the Institut Curie, Paris, France in 2001, his post-doc at the Rockefeller University, NY, USA, studying the mechanisms of action of IVIG, and identifying mouse FcgRIV. Since 2004 he joined Institut Pasteur, Paris, France and directs the research unit of Antibodies in Therapy & Pathology, focusing on mechanisms of antibody receptors & repertoires, severe allergy (anaphylaxis), autoimmunity and Ab-mediated immunotherapy. Since 2014 his lab uses droplet microfluidics to analyze antibody-secreting cells for their phenotype and their antibody repertoire in physiology and disease. He is an ERC grant recipient, and inventor on several patents including therapeutic antibodies and vaccines.

Agenda Sessions

  • Microfluidics and Engineered Mice for Antibody Selection and Validation